Conmed (CNMD) FCF Payout Ratio Growth (1y) (2013 - 2025)
Conmed (CNMD) FCF Payout Ratio Growth (1y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.00% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -67.77% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -7.45% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -51.96% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 9,472.45% |
| 10 | Conmed | 994.72 Mn | 959.69 Mn | 183.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.46% |
| Sep 30, 2025 | -1.06% |
| Jun 30, 2025 | 70.46% |
| Mar 31, 2025 | -27.94% |
| Dec 31, 2024 | 31.75% |
| Sep 30, 2024 | -14.51% |
| Jun 30, 2024 | -43.81% |
| Mar 31, 2024 | 130.18% |
| Dec 31, 2023 | 133.81% |
| Sep 30, 2023 | -52.50% |
| Jun 30, 2023 | -39.05% |
| Mar 31, 2023 | 56.95% |
| Dec 31, 2022 | -284.92% |
| Sep 30, 2022 | -14.00% |
| Jun 30, 2022 | 143.63% |
| Mar 31, 2022 | -682.46% |
| Dec 31, 2021 | -43.30% |
| Sep 30, 2021 | 105.84% |
| Jun 30, 2021 | -94.18% |
| Mar 31, 2021 | -95.27% |